Get the Stockscreener App
6.11
2.24%
-0.14
After Hours:
6.05
-0.06
-0.98%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $6.11, with a volume of 1.32M.
It is down -2.24% in the last 24 hours and down -17.88% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$6.25
Open:
$6.22
24h Volume:
1.32M
Relative Volume:
0.60
Market Cap:
$2.25B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-12.73
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
-10.28%
1M Performance:
-17.88%
6M Performance:
-25.12%
1Y Performance:
-40.10%
1-Day Range:
$6.055
$6.2366
1-Week Range:
$6.055
$6.86
52-Week Range:
$3.96
$11.46
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.11 | 2.25B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month - Corsicana Daily Sun
Oral Mucositis Market reached US$ 1.62 billion in 2023 and - openPR.com
Bausch + Lomb Brief: Adds Cause "Could Not Immediately Be Explained" - MarketScreener
Bausch + Lomb Brief: Announcing a Voluntary Recall of Intraocular Lenses (IOLs) On Its enVista Platform - MarketScreener
Bausch Health to Announce First Quarter Results on April 30 - guardonline.com
Bausch Health revenue by segment 2021-2024 - Statista
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Bausch Health Upsizes Private Offering to $4.4 Billion - TipRanks
Bausch Health upsizes senior notes offering to $4.4 billion By Investing.com - Investing.com South Africa
Bausch Health upsizes senior notes offering to $4.4 billion - Investing.com India
Bausch Health Prices Upsized Private Offering of Senior Secured Notes - MarketScreener
Bausch Health Announces Pricing Of Upsized Private Offering Of Senior Secured Notes - Marketscreener.com
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes - ACCESS Newswire
Shareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years ago - Yahoo Finance
Bausch Health announces debt refinancing plans By Investing.com - Investing.com South Africa
Bausch Health announces debt refinancing plans - Investing.com
Bausch Health Announces Conditional Redemption of Senior Notes - TipRanks
Bausch Health Brief: Announcing Conditional Redemption of Senior Notes -March 21, 2025 at 04:24 pm EDT - MarketScreener
Bausch Health's Massive $7.4B Debt Overhaul Extends Maturity to 2032 - StockTitan
After losing 25% in the past year, Bausch Health Companies Inc. (NYSE:BHC) institutional owners must be relieved by the recent gain - simplywall.st
Bausch Health finance plan gets thumbs up at Raymond James - Cantech Letter
BHC Stock Price, News and Analysis - Cantech Letter
Optical Coherence Tomography Devices Market Future Business - openPR
Raymond James maintains Bausch Health stock Market Perform By Investing.com - Investing.com South Africa
Raymond James maintains Bausch Health stock Market Perform - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities - Investing.com Australia
Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities By Investing.com - Investing.com South Africa
Bausch Health Launches $4 Billion Note Offering to Restructure Debt - TipRanks
Bausch Health Launches Syndication Of New Senior Secured Credit Facilities Totaling At Least $3.8 Bln - MarketScreener
Bausch Health Launches $3.8 Billion Credit Facilities -March 19, 2025 at 12:15 pm EDT - Marketscreener.com
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities - ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes - ACCESS Newswire
Intraocular Lens Market Research Methodologies Offers High - openPR
Bausch Health announces next steps in financining initiative - Yahoo Finance
Bausch Health Companies Announces Next Steps In Financing Initiative With J.P. Morgan - Marketscreener.com
Bausch Health seeks financing with J.P. Morgan aid By Investing.com - Investing.com South Africa
Bausch Health seeks financing with J.P. Morgan aid - Investing.com India
Bausch Health Brief: Says Has engaged J.P. Morgan in connection with Its previously announced financing objectives - Marketscreener.com
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan - Voice Of Alexandria
Bausch Health Taps JP Morgan to Lead Major Financial Restructuring Initiative - StockTitan
What is Zacks Research’s Forecast for BHC Q2 Earnings? - Defense World
Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies - Barchart
Microkeratome Market Detailed In New Research Report 2025 | - openPR
Overt Hepatic Encephalopathy Treatment Market: Key - openPR
Bausch Health Companies Inc. (NYSE:BHC) Receives $7.42 Consensus PT from Analysts - Defense World
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.06%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):